Literature DB >> 29949775

The Tumor Suppressor ARID1A Controls Global Transcription via Pausing of RNA Polymerase II.

Marco Trizzino1, Elisa Barbieri1, Ana Petracovici2, Shuai Wu1, Sarah A Welsh3, Tori A Owens1, Silvia Licciulli1, Rugang Zhang1, Alessandro Gardini4.   

Abstract

AT-rich interactive domain-containing proteins 1A and 1B (ARID1A and ARID1B) are mutually exclusive subunits of the chromatin remodeler SWI/SNF. ARID1A is the most frequently mutated chromatin regulator across all cancers, and ovarian clear cell carcinoma (OCCC) carries the highest prevalence of ARID1A mutations (∼57%). Despite evidence implicating ARID1A in tumorigenesis, the mechanism remains elusive. Here, we demonstrate that ARID1A binds active regulatory elements in OCCC. Depletion of ARID1A represses RNA polymerase II (RNAPII) transcription but results in modest changes to accessibility. Specifically, pausing of RNAPII is severely impaired after loss of ARID1A. Compromised pausing results in transcriptional dysregulation of active genes, which is compensated by upregulation of ARID1B. However, a subset of ARID1A-dependent genes is not rescued by ARID1B, including many p53 and estrogen receptor (ESR1) targets. Our results provide insight into ARID1A-mediated tumorigenesis and unveil functions of SWI/SNF in modulating RNAPII dynamics.
Copyright © 2018 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ARID1A; ARID1B; RNAPII; SWI/SNF; ovarian clear cell carcinoma; pausing; transcription

Mesh:

Substances:

Year:  2018        PMID: 29949775      PMCID: PMC6146183          DOI: 10.1016/j.celrep.2018.05.097

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  60 in total

Review 1.  ARID proteins come in from the desert.

Authors:  R D Kortschak; P W Tucker; R Saint
Journal:  Trends Biochem Sci       Date:  2000-06       Impact factor: 13.807

2.  Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters.

Authors:  Leighton J Core; Joshua J Waterfall; John T Lis
Journal:  Science       Date:  2008-12-04       Impact factor: 47.728

3.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features.

Authors:  Yang Liao; Gordon K Smyth; Wei Shi
Journal:  Bioinformatics       Date:  2013-11-13       Impact factor: 6.937

4.  c-Myc regulates transcriptional pause release.

Authors:  Peter B Rahl; Charles Y Lin; Amy C Seila; Ryan A Flynn; Scott McCuine; Christopher B Burge; Phillip A Sharp; Richard A Young
Journal:  Cell       Date:  2010-04-30       Impact factor: 41.582

5.  Pausing of RNA polymerase II regulates mammalian developmental potential through control of signaling networks.

Authors:  Lucy H Williams; George Fromm; Nolan G Gokey; Telmo Henriques; Ginger W Muse; Adam Burkholder; David C Fargo; Guang Hu; Karen Adelman
Journal:  Mol Cell       Date:  2015-03-12       Impact factor: 17.970

6.  The Sequence Alignment/Map format and SAMtools.

Authors:  Heng Li; Bob Handsaker; Alec Wysoker; Tim Fennell; Jue Ruan; Nils Homer; Gabor Marth; Goncalo Abecasis; Richard Durbin
Journal:  Bioinformatics       Date:  2009-06-08       Impact factor: 6.937

7.  Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy.

Authors:  Cigall Kadoch; Diana C Hargreaves; Courtney Hodges; Laura Elias; Lena Ho; Jeff Ranish; Gerald R Crabtree
Journal:  Nat Genet       Date:  2013-05-05       Impact factor: 38.330

8.  Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes.

Authors:  Jesse R Raab; Samuel Resnick; Terry Magnuson
Journal:  PLoS Genet       Date:  2015-12-30       Impact factor: 5.917

9.  Widespread changes in nucleosome accessibility without changes in nucleosome occupancy during a rapid transcriptional induction.

Authors:  Britta Mueller; Jakub Mieczkowski; Sharmistha Kundu; Peggy Wang; Ruslan Sadreyev; Michael Y Tolstorukov; Robert E Kingston
Journal:  Genes Dev       Date:  2017-03-29       Impact factor: 11.361

10.  The Primary Effect on the Proteome of ARID1A-mutated Ovarian Clear Cell Carcinoma is Downregulation of the Mevalonate Pathway at the Post-transcriptional Level.

Authors:  Aaron R Goldman; Benjamin G Bitler; Zachary Schug; Jose R Conejo-Garcia; Rugang Zhang; David W Speicher
Journal:  Mol Cell Proteomics       Date:  2016-09-21       Impact factor: 5.911

View more
  31 in total

1.  HDAC6 Inhibition Synergizes with Anti-PD-L1 Therapy in ARID1A-Inactivated Ovarian Cancer.

Authors:  Takeshi Fukumoto; Nail Fatkhutdinov; Joseph A Zundell; Evgenii N Tcyganov; Timothy Nacarelli; Sergey Karakashev; Shuai Wu; Qin Liu; Dmitry I Gabrilovich; Rugang Zhang
Journal:  Cancer Res       Date:  2019-07-16       Impact factor: 12.701

2.  PLK1 inhibition selectively induces apoptosis in ARID1A deficient cells through uncoupling of oxygen consumption from ATP production.

Authors:  Upadhyayula S Srinivas; Norbert S C Tay; Patrick Jaynes; Akshaya Anbuselvan; Gokula K Ramachandran; Joanna D Wardyn; Michal M Hoppe; Phuong Mai Hoang; Yanfen Peng; Sherlly Lim; May Yin Lee; Praveen C Peethala; Omer An; Akshay Shendre; Bryce W Q Tan; Sherlyn Jemimah; Manikandan Lakshmanan; Longyu Hu; Rekha Jakhar; Karishma Sachaphibulkij; Lina H K Lim; Shazib Pervaiz; Karen Crasta; Henry Yang; Patrick Tan; Chao Liang; Lena Ho; Vartika Khanchandani; Dennis Kappei; Wei Peng Yong; David S P Tan; Matteo Bordi; Silvia Campello; Wai Leong Tam; Christian Frezza; Anand D Jeyasekharan
Journal:  Oncogene       Date:  2022-03-02       Impact factor: 9.867

3.  Targeting the IRE1α/XBP1 Endoplasmic Reticulum Stress Response Pathway in ARID1A-Mutant Ovarian Cancers.

Authors:  Joseph A Zundell; Takeshi Fukumoto; Jianhuang Lin; Nail Fatkhudinov; Timothy Nacarelli; Andrew V Kossenkov; Qin Liu; Joel Cassel; Chih-Chi Andrew Hu; Shuai Wu; Rugang Zhang
Journal:  Cancer Res       Date:  2021-09-21       Impact factor: 13.312

4.  ARID1A loss derepresses a group of human endogenous retrovirus-H loci to modulate BRD4-dependent transcription.

Authors:  Chunhong Yu; Xiaoyun Lei; Fang Chen; Song Mao; Lu Lv; Honglu Liu; Xueying Hu; Runhan Wang; Licong Shen; Na Zhang; Yang Meng; Yunfan Shen; Jiale Chen; Pishun Li; Shi Huang; Changwei Lin; Zhuohua Zhang; Kai Yuan
Journal:  Nat Commun       Date:  2022-06-17       Impact factor: 17.694

5.  ARID1A mutation and genomic stability.

Authors:  Timothy Nacarelli; Bo Zhao; Xue Hao; Rugang Zhang
Journal:  Mol Cell Oncol       Date:  2020-02-23

Review 6.  ARID1 proteins: from transcriptional and post-translational regulation to carcinogenesis and potential therapeutics.

Authors:  Olena Odnokoz; Cindy Wavelet-Vermuse; Shelby L Hophan; Serdar Bulun; Yong Wan
Journal:  Epigenomics       Date:  2021-04-23       Impact factor: 4.778

7.  Chromatin remodeler Arid1a regulates subplate neuron identity and wiring of cortical connectivity.

Authors:  Daniel Z Doyle; Mandy M Lam; Adel Qalieh; Yaman Qalieh; Alice Sorel; Owen H Funk; Kenneth Y Kwan
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-25       Impact factor: 11.205

8.  Targeting Mitochondrial Metabolism in Clear Cell Carcinoma of the Ovaries.

Authors:  Xiaonan Zhang; Mihir Shetty; Valentino Clemente; Stig Linder; Martina Bazzaro
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

9.  MUC1-C Activates the BAF (mSWI/SNF) Complex in Prostate Cancer Stem Cells.

Authors:  Masayuki Hagiwara; Yota Yasumizu; Nami Yamashita; Hasan Rajabi; Atsushi Fushimi; Mark D Long; Wei Li; Atrayee Bhattacharya; Rehan Ahmad; Mototsugu Oya; Song Liu; Donald Kufe
Journal:  Cancer Res       Date:  2020-12-15       Impact factor: 13.312

10.  Genetic Characterization of Cancer of Unknown Primary Using Liquid Biopsy Approaches.

Authors:  Noemi Laprovitera; Irene Salamon; Francesco Gelsomino; Elisa Porcellini; Mattia Riefolo; Marianna Garonzi; Paola Tononi; Sabrina Valente; Silvia Sabbioni; Francesca Fontana; Nicolò Manaresi; Antonia D'Errico; Maria A Pantaleo; Andrea Ardizzoni; Manuela Ferracin
Journal:  Front Cell Dev Biol       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.